Novozymes A/S (NVZMF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
70.540.00 (0.00%)
As of 3:51PM EDT. Market open.
Loading interactive chart…
- Zacks
ICL or NVZMY: Which Is the Better Value Stock Right Now?
ICL vs. NVZMY: Which Stock Is the Better Value Option?
- Globe Newswire
Novozymes is unlocking growth with the ambition of doubling company revenue by 2030
With the launch of “Unlocking Growth – Powered by Biotech” Novozymes presents its 2025-strategy. It sets out an organic sales growth target of 5+% CAGR for the 5-year period until 2025, coupled with the ambition to double the company’s revenue by 2030. COPENHAGEN, DENMARK – 27 September 2021 – “Unlocking Growth – Powered by Biotech” is Novozymes’ strategy towards 2025 based on the solid foundation and successful execution of “Better Business with Biology”. As part of ‘Unlocking Growth’ Novozymes
- Globe Newswire
Novozymes announces its 2025 strategy: Unlocking growth – powered by biotech
Please read the full announcement in PDF Attachment 2021_46_Novozymes_announces_ 2025_strategy
© 2021 Verizon Media. All rights reserved.
